InnoPharmax Inc. (TPEX:4172)
Taiwan · Delayed Price · Currency is TWD 11.80
-0.05 (-0.42%)
Jul 9, 2026, 2:59 PM CST
InnoPharmax Market Cap
InnoPharmax has a market cap or net worth of 1.27 billion as of July 9, 2026. Its market cap has decreased by -35.16% in one year.
Market Cap
1.27B
Enterprise Value
1.13B
Revenue
68.99M
Ranking
n/a
PE Ratio
n/a
Stock Price
11.80
Market Cap Chart
Since September 13, 2012, InnoPharmax's market cap has decreased from 1.54B to 1.27B, a decrease of -17.66%. That is a compound annual growth rate of -1.40%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 9, 2026 | 1.27B | -29.76% |
| Dec 31, 2025 | 1.81B | 3.38% |
| Dec 31, 2024 | 1.75B | 5.76% |
| Dec 29, 2023 | 1.65B | 62.70% |
| Dec 30, 2022 | 1.02B | -32.67% |
| Dec 30, 2021 | 1.51B | 15.28% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Johnson Chemical Pharmaceutical Works | 2.27B |
| TSH Biopharm Corporation | 1.95B |
| GeneFerm Biotechnology | 1.43B |
| Excelsior Biopharma | 1.18B |
| Prince Pharmaceutical | 1.11B |
| Winston Medical Supply | 1.11B |
| DV Biomed | 1.03B |
| Anxo Pharmaceutical | 977.74M |